Bioengineering Bone Marrow Company at AOFAS
OssiumHealth processing bone marrow from organ donors at scale. They process and cryopreserve while ensuring the bone marrow is phenotypically and functionally equivalent to cells from living donors. The result is the world’s first bank of on-demand bone marrow. Sounds amazing for leukemia treatment, but why display at AOFAS?
Allograft Bone Matrix
How many surgeons really understand the difference between the various offerings in the bio market for bone healing? This has been an educational conundrum for 20 years. Into this relatively crowded market segment comes a new offering: OssiGraft Bone Matrix. The difference may be that the company is calling out a minimum number of osteoprogenitor cells which, at the least, raises the bar for comparison between products.
Recent Posts
See Allby Vince Vacketta, DPM Weight bearing CT (WBCT) has proven to be a valuable tool for foot and ankle surgeons. One study looking at the WBCT experience of an orthopedic practice found revenue neutral w
The American Orthopaedic Foot & Ankle Society (AOFAS) meeting in Louisville last week was a solid meeting with a great scientific program. But everyone knows that the exhibit halls pays for the event.
